Tanoue Y, Morita S, Ochiai Y, Zhang Q W, Hisahara M, Miyamoto K, Nishida T, Kawachi Y, Tominaga R, Yasui H
Department of Cardiovascular Surgery, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
J Heart Lung Transplant. 1996 Jan;15(1 Pt 1):43-50.
Lipid peroxidation is known to contribute to ischemia-reperfusion injury. U74500A is a 21-aminosteroid (lazaroid) that prevents lipid peroxidation without corticoid side effects. We examined the effect of U74500A on lung preservation using a canine orthotopic single left lung transplantation model.
Twelve adult mongrel dogs underwent left lung allotransplantation. The lungs of the donor dogs were flushed with University of Wisconsin solution (50 ml/kg). Six donor dogs were pretreated with U74500A (5 mg/kg intravenously) before preservation (group L, n = 6), whereas those dogs without pretreatment served as controls (group C, n = 6). Allografts were stored in University of Wisconsin solution for 24 hours at 1 degrees C. Left single lung transplantations were performed by means of standard technique. Before reperfusion, recipients in group L received another dose of U74500A. Arterial blood gas analysis and hemodynamic measurements were made by occluding the right pulmonary artery to evaluate the transplanted left lung function at a inspired oxygen fraction of 1.0. Serum lipid peroxide level was measured after 2 hours of reperfusion.
Arterial oxygen tension, arterial carbon dioxide tension, and left pulmonary vascular resistance at 6 hours after reperfusion were significantly better in group L than in group C (arterial oxygen tension: 510 +/- 66 and 219 +/- 149 mm Hg; arterial carbon dioxide tension: 47 +/- 16 and 68 +/- 14 mm Hg; left pulmonary vascular resistance: 2412 +/- 826 and 3904 +/- 1251 dyn center dot sec/cm5, group L and group C, respectively). Serum lipid peroxide level was significantly lower in group L (0.25 +/- 0.24 nmol/ml) than in group C (0.92 +/- 0.53).
The administration of U74500A prevented lipid peroxidation and preserved pulmonary allograft function after 24 hours of ischemia.
已知脂质过氧化作用会导致缺血再灌注损伤。U74500A是一种21 -氨基类固醇(拉扎罗类药物),可防止脂质过氧化且无皮质激素副作用。我们使用犬原位单左肺移植模型研究了U74500A对肺保存的影响。
12只成年杂种犬接受左肺同种异体移植。供体犬的肺用威斯康星大学溶液(50 ml/kg)冲洗。6只供体犬在保存前静脉注射U74500A(5 mg/kg)(L组,n = 6),而未进行预处理的犬作为对照组(C组,n = 6)。同种异体移植物在1℃的威斯康星大学溶液中保存24小时。通过标准技术进行左单肺移植。在再灌注前,L组的受体接受另一剂U74500A。通过阻断右肺动脉进行动脉血气分析和血流动力学测量,以在吸入氧分数为1.0时评估移植的左肺功能。再灌注2小时后测量血清脂质过氧化物水平。
再灌注6小时后,L组的动脉血氧张力、动脉血二氧化碳张力和左肺血管阻力明显优于C组(动脉血氧张力:510±66和219±149 mmHg;动脉血二氧化碳张力:47±16和68±14 mmHg;左肺血管阻力:2412±826和3904±1251 dyn·sec/cm5,分别为L组和C组)。L组的血清脂质过氧化物水平(0.25±0.24 nmol/ml)明显低于C组(0.92±0.53)。
给予U74500A可防止脂质过氧化,并在缺血24小时后保存肺同种异体移植物的功能。